Trial intelligence / Profile preview

TBE vaccine schedule optimization in adults aged 50+

2014-003549-90Phase 4Active

Sponsor
Region Sörmland
Start
Oct 2014
Modality
Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4 trial of FSME-IMMUN in tick-borne encephalitis (TBE) (2 arms), sponsored by Region Sörmland. Started Oct 2014; status: active.

02

Drugs

FSME-IMMUN
03

Conditions

tick-borne encephalitis (TBE)

Beyond the preview

Go deeper on 2014-003549-90.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-003549-90.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call